These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 26168700

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
    Brandt A, Jin CJ, Nolte K, Sellmann C, Engstler AJ, Bergheim I.
    Nutrients; 2017 Sep 14; 9(9):. PubMed ID: 28906444
    [Abstract] [Full Text] [Related]

  • 3. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
    Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I.
    Hepatology; 2009 Oct 14; 50(4):1094-104. PubMed ID: 19637282
    [Abstract] [Full Text] [Related]

  • 4. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
    Sellmann C, Jin CJ, Engstler AJ, De Bandt JP, Bergheim I.
    Eur J Nutr; 2017 Dec 14; 56(8):2519-2527. PubMed ID: 27496089
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.
    Wagnerberger S, Spruss A, Kanuri G, Volynets V, Stahl C, Bischoff SC, Bergheim I.
    Br J Nutr; 2012 Jun 14; 107(12):1727-38. PubMed ID: 22018861
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
    Jin CJ, Sellmann C, Engstler AJ, Ziegenhardt D, Bergheim I.
    Br J Nutr; 2015 Dec 14; 114(11):1745-55. PubMed ID: 26450277
    [Abstract] [Full Text] [Related]

  • 8. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice.
    Spruss A, Kanuri G, Uebel K, Bischoff SC, Bergheim I.
    Antioxid Redox Signal; 2011 Jun 14; 14(11):2121-35. PubMed ID: 21083420
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
    Sellmann C, Baumann A, Brandt A, Jin CJ, Nier A, Bergheim I.
    J Nutr; 2017 Nov 14; 147(11):2041-2049. PubMed ID: 28931589
    [Abstract] [Full Text] [Related]

  • 11. Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling.
    Li J, Sasaki GY, Dey P, Chitchumroonchokchai C, Labyk AN, McDonald JD, Kim JB, Bruno RS.
    J Nutr Biochem; 2018 Mar 14; 53():58-65. PubMed ID: 29190550
    [Abstract] [Full Text] [Related]

  • 12. Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function.
    Engstler AJ, Sellmann C, Jin CJ, Brandt A, Herz K, Priebs J, Bergheim I.
    Mol Nutr Food Res; 2017 May 14; 61(5):. PubMed ID: 28067024
    [Abstract] [Full Text] [Related]

  • 13. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
    Ushio M, Nishio Y, Sekine O, Nagai Y, Maeno Y, Ugi S, Yoshizaki T, Morino K, Kume S, Kashiwagi A, Maegawa H.
    Am J Physiol Endocrinol Metab; 2013 Jul 15; 305(2):E293-304. PubMed ID: 23715726
    [Abstract] [Full Text] [Related]

  • 14. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
    Baumann A, Jin CJ, Brandt A, Sellmann C, Nier A, Burkard M, Venturelli S, Bergheim I.
    Nutrients; 2020 Mar 30; 12(4):. PubMed ID: 32235497
    [Abstract] [Full Text] [Related]

  • 15. fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease.
    Guo XF, Gao JL, Li JM, Li D.
    Food Funct; 2017 Nov 15; 8(11):4053-4061. PubMed ID: 28972610
    [Abstract] [Full Text] [Related]

  • 16. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y, Burrington CM, Graff EC, Zhang J, Judd RL, Suksaranjit P, Kaewpoowat Q, Davenport SK, O'Neill AM, Greene MW.
    Am J Physiol Endocrinol Metab; 2016 Mar 15; 310(6):E418-39. PubMed ID: 26670487
    [Abstract] [Full Text] [Related]

  • 17. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

  • 18. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
    Spruss A, Henkel J, Kanuri G, Blank D, Püschel GP, Bischoff SC, Bergheim I.
    Mol Med; 2012 Dec 06; 18(1):1346-55. PubMed ID: 22952059
    [Abstract] [Full Text] [Related]

  • 19. Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction.
    Brandt A, Csarmann K, Hernández-Arriaga A, Baumann A, Staltner R, Halilbasic E, Trauner M, Camarinha-Silva A, Bergheim I.
    J Nutr Biochem; 2024 Jan 06; 123():109495. PubMed ID: 37871765
    [Abstract] [Full Text] [Related]

  • 20. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
    Rahman K, Desai C, Iyer SS, Thorn NE, Kumar P, Liu Y, Smith T, Neish AS, Li H, Tan S, Wu P, Liu X, Yu Y, Farris AB, Nusrat A, Parkos CA, Anania FA.
    Gastroenterology; 2016 Oct 06; 151(4):733-746.e12. PubMed ID: 27342212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.